Opendata, web and dolomites

CAPRI SIGNED

Treating the Chronic Pain Patient earlier in the Pathway

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "CAPRI" data sheet

The following table provides information about the project.

Coordinator
CAPRI MEDICAL LIMITED 

Organization address
address: OFFICE 201 BUSINESS INNOVATION CENTRE NATIONAL UNIVERSITY OF IRELAND GALWAY,
city: GALWAY
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 3˙423˙556 €
 EC max contribution 2˙396˙489 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-SMEInst-2018-2020-3
 Funding Scheme SME-2b
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2022-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CAPRI MEDICAL LIMITED IE (GALWAY) coordinator 2˙396˙489.00

Map

 Project objective

Persistent postoperative chronic pain (POCP) is defined as pain lasting for two or more months after surgery, when other causes of pain are excluded, such as cancer or chronic infection. The goal of the Capri-Stim project is to develop a product to replace current pain medication and nerve block injectable approaches for chronic pain.

Capri-Stim is the only implant suitable for postoperative pain having an indwell duration of over 5 years with no side effects. Capri-Stim only requires one injection, is a low risk class 2 device, has an average selling price (ASP) of 50% less than current competitors. Capri-Stim enables the patient being discharged from the healthcare system after one visit and self managed from home. The technology is protected by 4 patent filings

Pain medication is addictive and comes with significant side effects. Nerve block injectables need to be repeated at least every 3 months and have their own significant side effects. Other technologies have attempted to replace these approaches but have all failed as they all involve significant invasive surgical procedures, are susceptible to lead migration, are too large for intramuscular placement with inaccurate placement causing reduced efficacy.

Developed in NUI-Galway, Capri-Stim is a new product and the only implant suitable for postoperative pain having an indwell duration of over 5 years with no side effects. Capri-Stim only requires one injection, is a low risk class 2 device, has an ASP of 50% less than current competitors. Overall the Capri-Stim product means that the patient can be discharged from the healthcare system after one visit and self managed from home.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAPRI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CAPRI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More